TW200626608A - Macrolides - Google Patents

Macrolides

Info

Publication number: TW200626608A
Authority: TW; Taiwan
Prior art keywords: compounds; methods; macrolides; excerpt; intermediates
Prior art date: 2004-12-21

Application number

TW094145385A

Other languages

English (en)

Inventor

Louis Stanley Chupak

Mark Edward Flanagan

Takushi Kaneko

Thomas Victor Magee

Mark Carl Noe

Usa Reilly

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-21

Filing date

2005-12-20

Publication date

2006-08-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200626608(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-20 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-08-01 Publication of TW200626608A publication Critical patent/TW200626608A/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Cephalosporin Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Tires In General (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW094145385A 2004-12-21 2005-12-20 Macrolides TW200626608A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63809704P	2004-12-21	2004-12-21
US71753005P	2005-09-14	2005-09-14

Publications (1)

Publication Number	Publication Date
TW200626608A true TW200626608A (en)	2006-08-01

Family

ID=35809765

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094145385A TW200626608A (en)	2004-12-21	2005-12-20	Macrolides

Country Status (35)

Country	Link
US (1)	US7462600B2 (zh)
EP (2)	EP2233493A1 (zh)
JP (1)	JP4111994B1 (zh)
KR (1)	KR100897678B1 (zh)
CN (1)	CN101120011A (zh)
AP (1)	AP2007004026A0 (zh)
AR (1)	AR052824A1 (zh)
AT (1)	ATE459633T1 (zh)
AU (1)	AU2005317735B2 (zh)
BR (1)	BRPI0519135A2 (zh)
CA (1)	CA2591746A1 (zh)
CR (1)	CR9202A (zh)
DE (1)	DE602005019786D1 (zh)
DK (1)	DK1836211T3 (zh)
EA (1)	EA011281B1 (zh)
ES (1)	ES2339871T3 (zh)
GE (1)	GEP20094834B (zh)
GT (1)	GT200500378A (zh)
HN (1)	HN2005036113A (zh)
HR (1)	HRP20100253T1 (zh)
IL (1)	IL183661A0 (zh)
MA (1)	MA29108B1 (zh)
MX (1)	MX2007007598A (zh)
NL (1)	NL1030713C2 (zh)
NO (1)	NO20073367L (zh)
PE (1)	PE20060948A1 (zh)
PL (1)	PL1836211T3 (zh)
PT (1)	PT1836211E (zh)
SI (1)	SI1836211T1 (zh)
TN (1)	TNSN07233A1 (zh)
TW (1)	TW200626608A (zh)
UA (1)	UA85937C2 (zh)
UY (1)	UY29285A1 (zh)
WO (1)	WO2006067589A1 (zh)
ZA (1)	ZA200705108B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8367669B2 (en) *	2005-06-15	2013-02-05	Vanderbilt University	Inhibitors of hemeprotein-catalyzed lipid peroxidation
US9133212B1 (en)	2005-06-15	2015-09-15	Vanderbilt University	Inhibitors of hemeprotein-catalyzed lipid peroxidation
EP1928893A2 (en)	2005-08-24	2008-06-11	Rib-X Pharmaceuticals, Inc.	Triazole compounds and methods of making and using the same
WO2008110918A2 (en) *	2007-03-13	2008-09-18	Pfizer Products Inc.	Erythromycin-based macrolides
AU2008227216A1 (en) *	2007-03-21	2008-09-25	Creative Antibiotics Sweden Ab	Method and means for preventing and inhibiting type III secretion in infections caused by gram-negative bacteria
WO2009053259A1 (en) *	2007-10-25	2009-04-30	Sandoz Ag	Process for the production of telithromycin
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
RU2495878C2 (ru)	2007-12-21	2013-10-20	Ф.Хоффманн-Ля Рош Аг	Гетероциклические антивирусные соединения
JP5662445B2 (ja)	2009-08-13	2015-01-28	バジリアファルマスーチカアーゲーＢａｓｉｌｅａＰｈａｒｍａｃｅｕｔｉｃａＡＧ	新規マクロライド及びその使用
HRP20160168T1 (hr) *	2010-03-22	2016-03-25	Cempra Pharmaceuticals Inc	Kristalne forme makrolida i njihova uporaba
EP2696873B1 (en)	2011-04-12	2022-08-03	The United States of America, as represented by The Secretary, Department of Health and Human Services	Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
CN102558047B (zh) *	2011-12-14	2013-10-30	天津药物研究院药业有限责任公司	3-甲基喹啉的制备方法
WO2013148891A1 (en)	2012-03-27	2013-10-03	Cempra Pharmaceuticals, Inc.	Parenteral formulations for administering macrolide antibiotics
US9611224B2 (en)	2012-07-13	2017-04-04	Hoffmann-La Roche Inc.	Antiproliferative benzo [B] azepin-2-ones
KR101663864B1 (ko) *	2013-04-19	2016-10-07	영남대학교 산학협력단	아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염을 유효성분으로 함유하는 염증성 장질환의 예방 또는 치료용 약학조성물
TW201534586A (zh)	2013-06-11	2015-09-16	Orion Corp	新穎ｃｙｐ１７抑制劑／抗雄激素劑
CN103739643A (zh) *	2013-12-30	2014-04-23	华东理工大学	利用分子印迹技术对红霉素进行回收分离纯化的方法
CN104230891B (zh) *	2014-08-27	2016-03-30	于宗光	一种托匹司他的制备方法
CN110234323A (zh) *	2016-10-04	2019-09-13	Ti生物制药有限公司	具有抗菌活性的酮内酯
CN114340616A (zh) *	2019-06-04	2022-04-12	海格生物科学有限责任公司	作为食欲肽拮抗剂的吡唑和咪唑衍生物、组合物以及方法
JP2022534704A (ja)	2019-06-04	2022-08-03	ヘイガーバイオサイエンシズ，エルエルシー	オレキシンアンタゴニストとしてのイミダゾロ誘導体、組成物、及び方法
CN111793022A (zh) *	2020-04-27	2020-10-20	滁州拜奥生物科技有限公司	一种3-甲基喹啉的制备方法
EP4580620A2 (en) *	2022-09-01	2025-07-09	Hager Biosciences, LLC	Pyrazole and imidazole derivatives as dual orexin and kappa-opioid receptors modulators, composition, methods for treating neurological and psychiatric disorders

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2653899A (en)	1952-04-14	1953-09-29	Lilly Co Eli	Erythromycin, its salts, and method of preparation
US2823203A (en)	1954-06-24	1958-02-11	Abbott Lab	Method of producing substantially pure erythromycin a
US4331803A (en)	1980-06-04	1982-05-25	Taisho Pharmaceutical Co., Ltd.	Novel erythromycin compounds
YU43006B (en)	1981-03-06	1989-02-28	Pliva Pharm & Chem Works	Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en)	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4742049A (en) *	1986-06-04	1988-05-03	Abbott Laboratories	Semisynthetic erythromycin antibiotics
US5075289A (en)	1988-06-07	1991-12-24	Abbott Laboratories	9-r-azacyclic erythromycin antibiotics
IE70593B1 (en)	1989-09-29	1996-12-11	Eisai Co Ltd	Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5523399A (en)	1991-12-27	1996-06-04	Taisho Pharmaceutical Co., Ltd.	5-O-desosaminylerythronolide derivatives
US5527780A (en)	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2697524B1 (fr) *	1992-11-05	1994-12-23	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr)	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5629322A (en)	1994-11-15	1997-05-13	Merck & Co., Inc.	Cyclic amidine analogs as inhibitors of nitric oxide synthase
FR2727969B1 (fr) *	1994-12-09	1997-01-17	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5747466A (en) *	1995-11-08	1998-05-05	Abbott Laboratories	3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr)	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
AU2340797A (en) *	1996-05-07	1997-11-26	Abbott Laboratories	6-o-substituted erythromycins and method for making them
US5750510A (en) *	1997-04-04	1998-05-12	Abbott Laboratories	3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) *	1996-05-14	1998-08-14	Hoechst Marion Roussel Inc	Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
US6271255B1 (en)	1996-07-05	2001-08-07	Biotica Technology Limited	Erythromycins and process for their preparation
FR2751656B1 (fr) *	1996-07-24	1998-10-16	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP1291351B1 (en)	1996-09-04	2005-07-13	Abbott Laboratories	6-0 substituted ketolides having antibacterial activity
US5804565A (en)	1996-09-24	1998-09-08	Taisho Pharmaceutical Co., Ltd.	Erythromycin A derivatives
JP4077882B2 (ja) *	1996-11-27	2008-04-23	大正製薬株式会社	エリスロマイシンａ誘導体
AU6421398A (en)	1997-03-24	1998-10-20	Taisho Pharmaceutical Co., Ltd.	Erythromycin a derivatives
AU6932098A (en)	1997-05-09	1998-12-08	Pfizer Products Inc.	Erythromycin derivatives
US20020025937A1 (en)	2000-03-20	2002-02-28	Yong-Jin Wu	9-oxime erythromycin derivatives
EP0895999A1 (en)	1997-08-06	1999-02-10	Pfizer Products Inc.	C-4" substituted macrolide antibiotics
ZA987689B (en)	1997-09-02	1999-02-24	Abbott Lab	3-descladinose 6-O substituted erythromycin derivatives
US6034069A (en) *	1997-09-30	2000-03-07	Abbott Laboratories	3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
JP2003527301A (ja)	1997-10-29	2003-09-16	大正製薬株式会社	エリスロマイシンａ誘導体
HN1998000159A (es) *	1997-10-29	1999-02-09	Monsanto Co	Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es)	1997-10-29	2000-05-24	Pfizer Prod Inc	Derivados de eritromicina triciclicos
AP1060A (en) *	1998-01-02	2002-04-23	Pfizer Prod Inc	Novel erythromycin derivatives.
AP9801420A0 (en)	1998-01-02	1998-12-31	Pfizer Prod Inc	Novel macrolides.
ES2226282T3 (es)	1998-03-03	2005-03-16	Pfizer Products Inc.	Antibioticos macrilidos de 3,6-cetal.
US5955440A (en) *	1998-03-27	1999-09-21	Abbott Laboratories	Macrolide LHRH antagonists
US6248719B1 (en)	1998-06-03	2001-06-19	Pfizer Inc	Tricyclic 3-keto derivatives of 6-O-methylerthromycin
JP4573925B2 (ja) *	1998-07-09	2010-11-04	アベンティス・ファーマ・ソシエテ・アノニム	新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
US6020521A (en)	1998-08-26	2000-02-01	Abbott Laboratories	Macrolide LHRH antagonists
US6387885B1 (en) *	1998-08-26	2002-05-14	Abbott Laboratories	3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6262030B1 (en)	1998-11-03	2001-07-17	Pfizer Inc.	Erythromycin derivatives
SK5812001A3 (en)	1998-11-03	2001-12-03	Pfizer Prod Inc	Novel macrolide antibiotics
AU6484199A (en) *	1998-12-10	2000-06-26	Pfizer Products Inc.	Carbamate and carbazate ketolide antibiotics
OA11753A (en)	1999-01-27	2005-07-19	Pfizer Prod Inc	Ketolide antibiotics.
US6054435A (en) *	1999-03-19	2000-04-25	Abbott Laboratories	6-O-substituted macrolides having antibacterial activity
US6395710B1 (en) *	1999-04-16	2002-05-28	Kosan Biosciences, Inc.	Macrolide antiinfective agents
CN1373767A (zh) *	1999-04-16	2002-10-09	奥索-麦克尼尔药品公司	酮式大环内酯抗菌剂
US6939861B2 (en)	1999-04-16	2005-09-06	Kosan Biosciences, Inc.	Amido macrolides
US20020077302A1 (en)	1999-04-23	2002-06-20	Yong-Jin Wu	Tricyclic erythromycin derivatives
US20020061857A1 (en)	1999-04-23	2002-05-23	Yong-Jin Wu	9-amino-3-oxo erythromycin derivatives
US6355620B1 (en) *	1999-05-14	2002-03-12	Abbott Laboratories	C-2 modified erythromycin derivatives
KR20020016799A (ko)	1999-05-24	2002-03-06	데이비드 존 우드	13-메틸-에리트로마이신 유도체
JP2001072669A (ja)	1999-09-07	2001-03-21	Showa Kako Kk	７−クロロ−２，４（１ｈ，３ｈ）−キナゾリンジオンの製造方法
US6569836B2 (en) *	1999-12-02	2003-05-27	Abbott Laboratories	6-O-alkyl-2-nor-2-substituted ketolide derivatives
EP1114826A3 (en)	1999-12-29	2001-10-31	Pfizer Products Inc.	Novel antibacterial and prokinetic macrolides
EP1122261A3 (en)	2000-01-31	2001-09-26	Pfizer Products Inc.	13 and 14-membered antibacterial macrolides
JP2001261694A (ja)	2000-03-06	2001-09-26	Pfizer Prod Inc	ケトライド抗生物質
EP1146051A3 (en)	2000-04-10	2001-10-31	Pfizer Products Inc.	Erythromycin A derivatives
US20020061856A1 (en)	2000-04-24	2002-05-23	Yong-Jin Wu	Novel tricyclic erythromycin derivatives
EP1167376B1 (en)	2000-06-30	2004-07-14	Pfizer Products Inc.	Macrolide antibiotics
US20020115621A1 (en)	2000-08-07	2002-08-22	Wei-Gu Su	Macrolide antibiotics
CZ20031751A3 (cs)	2000-12-21	2004-03-17	Glaxo Group Limited	Makrolidy
US20020132782A1 (en) *	2001-01-18	2002-09-19	Zhenkun Ma	9-amino erythromycin derivatives with antibacterial activity
CA2451391A1 (en) *	2001-07-03	2003-01-16	Chiron Corporation	C12 modified erythromycin macrolides and ketolides having antibacterial activity
US7022679B2 (en)	2002-05-13	2006-04-04	Enanta Pharmaceuticals, Inc.	Processes for the preparation of 6-11 bicyclic erythromycin derivatives
US7064110B2 (en)	2002-05-13	2006-06-20	Enanta Pharmaceuticals, Inc.	6-11 bicycle ketolide derivatives
JPWO2004094407A1 (ja)	2003-04-21	2006-07-13	第一製薬株式会社	５員複素環誘導体
WO2006080954A1 (en)	2004-07-28	2006-08-03	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
WO2006046112A2 (en)	2004-10-25	2006-05-04	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
GB0424951D0 (en)	2004-11-11	2004-12-15	Glaxo Group Ltd	Novel compounds
JP2008522978A (ja)	2004-12-07	2008-07-03	エナンタファーマシューティカルズインコーポレイテッド	３，６−ビシクロライド
US7312201B2 (en)	2004-12-13	2007-12-25	Enanta Pharmaceuticals, Inc.	Tetracyclic bicyclolides
WO2006065721A2 (en)	2004-12-13	2006-06-22	Enanta Pharmaceuticals, Inc.	11, 12-lactone bicyclolides

2005
- 2005-12-12 CA CA002591746A patent/CA2591746A1/en not_active Abandoned
- 2005-12-12 HR HR20100253T patent/HRP20100253T1/hr unknown
- 2005-12-12 KR KR1020077014160A patent/KR100897678B1/ko not_active Expired - Fee Related
- 2005-12-12 DE DE602005019786T patent/DE602005019786D1/de not_active Expired - Lifetime
- 2005-12-12 AT AT05813939T patent/ATE459633T1/de not_active IP Right Cessation
- 2005-12-12 EP EP10154783A patent/EP2233493A1/en not_active Withdrawn
- 2005-12-12 UA UAA200706959A patent/UA85937C2/uk unknown
- 2005-12-12 AU AU2005317735A patent/AU2005317735B2/en not_active Ceased
- 2005-12-12 EP EP05813939A patent/EP1836211B1/en not_active Expired - Lifetime
- 2005-12-12 CN CNA2005800482465A patent/CN101120011A/zh active Pending
- 2005-12-12 ES ES05813939T patent/ES2339871T3/es not_active Expired - Lifetime
- 2005-12-12 DK DK05813939.5T patent/DK1836211T3/da active
- 2005-12-12 AP AP2007004026A patent/AP2007004026A0/xx unknown
- 2005-12-12 BR BRPI0519135-1A patent/BRPI0519135A2/pt not_active IP Right Cessation
- 2005-12-12 EA EA200701113A patent/EA011281B1/ru not_active IP Right Cessation
- 2005-12-12 GE GEAP200510142A patent/GEP20094834B/en unknown
- 2005-12-12 JP JP2007547694A patent/JP4111994B1/ja not_active Expired - Fee Related
- 2005-12-12 PL PL05813939T patent/PL1836211T3/pl unknown
- 2005-12-12 MX MX2007007598A patent/MX2007007598A/es active IP Right Grant
- 2005-12-12 WO PCT/IB2005/003829 patent/WO2006067589A1/en not_active Ceased
- 2005-12-12 SI SI200530941T patent/SI1836211T1/sl unknown
- 2005-12-12 PT PT05813939T patent/PT1836211E/pt unknown
- 2005-12-14 PE PE2005001462A patent/PE20060948A1/es not_active Application Discontinuation
- 2005-12-19 HN HN2005036113A patent/HN2005036113A/es unknown
- 2005-12-20 TW TW094145385A patent/TW200626608A/zh unknown
- 2005-12-20 GT GT200500378A patent/GT200500378A/es unknown
- 2005-12-20 NL NL1030713A patent/NL1030713C2/nl not_active IP Right Cessation
- 2005-12-20 AR ARP050105370A patent/AR052824A1/es unknown
- 2005-12-21 US US11/313,523 patent/US7462600B2/en not_active Expired - Fee Related
- 2005-12-21 UY UY29285A patent/UY29285A1/es not_active Application Discontinuation
2007
- 2007-06-04 IL IL183661A patent/IL183661A0/en unknown
- 2007-06-15 ZA ZA200705108A patent/ZA200705108B/xx unknown
- 2007-06-20 TN TNP2007000233A patent/TNSN07233A1/fr unknown
- 2007-06-21 CR CR9202A patent/CR9202A/es not_active Application Discontinuation
- 2007-06-21 MA MA30024A patent/MA29108B1/fr unknown
- 2007-06-29 NO NO20073367A patent/NO20073367L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2006067589A1 (en)	2006-06-29
HN2005036113A (es)	2010-12-06
JP2008524319A (ja)	2008-07-10
JP4111994B1 (ja)	2008-07-02
PE20060948A1 (es)	2006-10-11
AU2005317735B2 (en)	2009-06-04
NO20073367L (no)	2007-09-05
ZA200705108B (en)	2009-01-28
ES2339871T3 (es)	2010-05-26
EA011281B1 (ru)	2009-02-27
MX2007007598A (es)	2007-07-25
US20060135447A1 (en)	2006-06-22
AR052824A1 (es)	2007-04-04
EP1836211A1 (en)	2007-09-26
NL1030713C2 (nl)	2006-12-12
EA200701113A1 (ru)	2007-12-28
GT200500378A (es)	2006-11-28
HRP20100253T1 (hr)	2010-06-30
PT1836211E (pt)	2010-04-08
EP1836211B1 (en)	2010-03-03
EP2233493A1 (en)	2010-09-29
MA29108B1 (fr)	2007-12-03
BRPI0519135A2 (pt)	2008-12-23
CN101120011A (zh)	2008-02-06
UY29285A1 (es)	2006-07-31
GEP20094834B (en)	2009-11-25
NL1030713A1 (nl)	2006-06-22
ATE459633T1 (de)	2010-03-15
TNSN07233A1 (fr)	2008-11-21
IL183661A0 (en)	2007-09-20
CR9202A (es)	2007-07-16
AP2007004026A0 (en)	2007-06-30
DE602005019786D1 (de)	2010-04-15
PL1836211T3 (pl)	2010-07-30
CA2591746A1 (en)	2006-06-29
AU2005317735A1 (en)	2006-06-29
SI1836211T1 (sl)	2010-04-30
KR20070089191A (ko)	2007-08-30
UA85937C2 (uk)	2009-03-10
US7462600B2 (en)	2008-12-09
DK1836211T3 (da)	2010-05-17
KR100897678B1 (ko)	2009-05-14

Publication	Publication Date	Title
TW200626608A (en)	2006-08-01	Macrolides
MY155649A (en)	2015-11-13	Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
MXPA05009595A (es)	2005-11-04	Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
WO2005013892A3 (en)	2005-06-16	Hydrolytically-resistant boron-containing therapeutics and methods of use
MY140826A (en)	2010-01-29	Substituted pyrazoline compounds, their preparation and use as medicaments.
CL2009000349A1 (es)	2010-02-19	Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
BRPI0408236A (pt)	2006-03-01	método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
EA201200318A1 (ru)	2012-09-28	Гетероциклические оксимы
ITMI20041550A1 (it)	2004-10-29	Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
EA200801998A1 (ru)	2009-04-28	ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
MX2009007345A (es)	2010-02-22	Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo.
WO2008087367A3 (fr)	2008-11-06	Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
TW200611695A (en)	2006-04-16	Pyrrolopyridine derivatives
BRPI0905687A8 (pt)	2019-05-21	composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto
TW200745043A (en)	2007-12-16	Substituted pyrazoline compounds, their preparation and use as medicaments
WO2010075280A3 (en)	2010-08-19	Coumarin-based compounds for the treatment of alzheimer's disease and cancer
EA200970387A1 (ru)	2009-10-30	Соль п-толуолсульфокислоты 5-амино-3-(2`-о-ацетил-3`-дезокси-бета-d-рибофуранозил)-3н-тиазоло[4,5-d]пиримидин-2-она и способы получения
MX2009010374A (es)	2010-03-04	Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
MX2007011009A (es)	2007-09-26	Compuestos de piperidina 3,4,5-substituidos.
EA200702253A1 (ru)	2008-04-28	Фармацевтическая композиция
EP1817312A4 (en)	2009-11-04	MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
TW200738699A (en)	2007-10-16	4-Substituted pyrazoline compounds, their preparation and use as medicaments
EA201000141A1 (ru)	2010-06-30	Новые триазены для лечения рака
MX2009013482A (es)	2010-01-27	Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.
MX2021005423A (es)	2021-09-08	Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.